Blueshift Asset Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1727827 RED BANK, NJ

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,149,184

+$532,079 QoQ

Shares Held

1,843

+89.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#618

of 1,322 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Blueshift Asset Management, LLC holds $9,217,770 across 26 Biotechnology names. REGN ranks #1 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	1,843	$1,149,184
2	ROIV	Roivant Sciences Ltd.	30,383	$1,075,254
3	AXSM	Axsome Therapeutics, Inc.	2,834	$693,678
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,118	$637,581
5	APGE	Apogee Therapeutics, Inc.	4,209	$558,660
6	INSM	INSMED Inc	4,800	$511,776
7	BMRN	Biomarin Pharmaceutical Inc	8,143	$465,942
8	ARWR	Arrowhead Pharmaceuticals, Inc.	4,819	$392,796

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,149,184	1,843	+89.4%	Shares	Sole	2026-08-14
2025-03-31	$617,105	973	-25.3%	Shares	Sole	2025-05-08
2024-12-31	$928,165	1,303	+284.4%	Shares	Sole	2025-02-11
2024-09-30	$356,370	339	-75.8%	Shares	Sole	2024-11-13
2023-06-30	$1,005,956	1,400	+324.2%	Shares	Sole	2023-08-15
2022-12-31	$238,091	330	-58.4%	Shares	Sole	2023-02-14
2021-12-31	$500,795	793	-49.9%	Shares	Sole	2022-02-11
2021-09-30	$957,394	1,582	-30.7%	Shares	Sole	2021-11-12
2021-03-31	$1,079,705	2,282	—	Shares	Sole	2021-05-06
No filing history on record for this holder in this stock.